[1]
|
(2020) The Chinese Guidelines for the Diagnosis and Treatment of Invasive Fungal Disease in Patients with Hematolog-ical Disorders and Cancers (the 6th Revision). Chinese Journal of Internal Medicine, 59, 754-763.
|
[2]
|
Brown, G.D., Denning, D.W., Gow, N.A., et al. (2012) Hidden Killers: Human Fungal Infections. Science Translational Medicine, 4, 165rv13. https://doi.org/10.1126/scitranslmed.3004404
|
[3]
|
Ye, F., Xie, J.X., Zeng, Q.S., et al. (2012) Retrospec-tive Analysis of 76 Immunocompetent Patients with Primary Pulmonary Cryptococcosis. Lung, 190, 339-346. https://doi.org/10.1007/s00408-011-9362-8
|
[4]
|
Hsu, L.Y., Lee, D.G., Yeh, S.P., et al. (2015) Epidemiology of Invasive Fungal Diseases among Patients with Haematological Disorders in the Asia-Pacific: A Prospective Observa-tional Study. Clinical Microbiology and Infection, 21, 594.e7-11. https://doi.org/10.1016/j.cmi.2015.02.019
|
[5]
|
Valentine, J.C., Morrissey, C.O., Tacey, M.A., et al. (2020) A Pop-ulation-Based Analysis of Attributable Hospitalisation Costs of Invasive Fungal Diseases in Haematological Malignancy Patients Using Data Linkage of State-Wide Registry and Costing Databases: 2009-2015. Mycoses, 63, 162-171. https://doi.org/10.1111/myc.13033
|
[6]
|
Jeong, W., Keighley, C., Wolfe, R., et al. (2019) The Epidemiology and Clinical Manifestations of Mucormycosis: A Systematic Review and Meta-Analysis of Case Reports. Clinical Microbi-ology and Infection, 25, 26-34.
https://doi.org/10.1016/j.cmi.2018.07.011
|
[7]
|
Liao, Y., Chen, M., Hartmann, T., et al. (2013) Epidemiology of Opportunistic Invasive Fungal Infections in China: Review of Literature. Chinese Medical Journal, 126, 361-368.
|
[8]
|
Lionakis, M.S. and Levitz, S.M. (2018) Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts. Annual Review of Immunology, 36, 157-191. https://doi.org/10.1146/annurev-immunol-042617-053318
|
[9]
|
Gao, Y. and Soubani, A. (2019) Advances in the Diagnosis and Management of Pulmonary Aspergillosis. Advances in Respiratory Medicine, 87, 231-243. https://doi.org/10.5603/ARM.2019.0061
|
[10]
|
Wald, A., Leisenring, W., Van Burik, J.A., et al. (1997) Epidemiol-ogy of Aspergillus Infections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation. The Journal of Infectious Diseases, 175, 1459-1466.
https://doi.org/10.1086/516480
|
[11]
|
Kontoyiannis, D.P. and Bodey, G.P. (2002) Invasive Aspergillosis in 2002: An Update. European Journal of Clinical Microbiology & Infectious Diseases, 21, 161-172. https://doi.org/10.1007/s10096-002-0699-z
|
[12]
|
Marr, K.A., Carter, R.A., Crippa, F., et al. (2002) Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients. Clinical Infectious Diseases, 34, 909-917. https://doi.org/10.1086/339202
|
[13]
|
Kaur, R., Dhakad, M.S., Goyal, R., et al. (2016) Spectrum of Op-portunistic Fungal Infections in HIV/AIDS Patients in Tertiary Care Hospital in India. Canadian Journal of Infectious Diseases and Medical Microbiology, 2016, Article ID: 2373424. https://doi.org/10.1155/2016/2373424
|
[14]
|
Benito, N., Moreno, A., Miro, J.M., et al. (2012) Pulmonary Infections in HIV-Infected Patients: An Update in the 21st Century. European Respiratory Journal, 39, 730-745. https://doi.org/10.1183/09031936.00200210
|
[15]
|
Van de Veerdonk, F.L. and Netea, M.G. (2010) T-Cell Subsets and Antifungal Host Defenses. Current Fungal Infection Reports, 4, 238-243. https://doi.org/10.1007/s12281-010-0034-6
|
[16]
|
Speakman, E.A., Dambuza, I.M., Salazar, F., et al. (2020) T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors. Trends in Immunology, 41, 61-76. https://doi.org/10.1016/j.it.2019.11.007
|
[17]
|
Verma, A., Wüthrich, M., Deepe, G., et al. (2014) Adaptive Immunity to Fungi. Cold Spring Harbor Perspectives in Medicine, 5, a019612. https://doi.org/10.1101/cshperspect.a019612
|
[18]
|
Schmidt, S., Tramsen, L. and Lehrnbecher, T. (2017) Natural Killer Cells in Antifungal Immunity. Frontiers in Immunology, 8, 1623. https://doi.org/10.3389/fimmu.2017.01623
|
[19]
|
Mcdermott, A.J. and Klein, B.S. (2018) Helper T-Cell Responses and Pulmonary Fungal Infections. Immunology, 155, 155-163. https://doi.org/10.1111/imm.12953
|
[20]
|
Dewi, I.M.W., Van de Veerdonk, F.L. and Gresnigt, M.S. (2017) The Multifaceted Role of T-Helper Responses in Host De-fense against Aspergillus fumigatus. Journal of Fungi (Basel), 3, 55. https://doi.org/10.3390/jof3040055
|
[21]
|
Bozza, S., Perruccio, K., Montagnoli, C., et al. (2003) A Dendritic Cell Vaccine against Invasive Aspergillosis in Allogeneic Hematopoietic Transplantation. Blood, 102, 3807-3814. https://doi.org/10.1182/blood-2003-03-0748
|
[22]
|
Cenci, E., Mencacci, A., Bacci, A., et al. (2000) T Cell Vaccina-tion in Mice with Invasive Pulmonary Aspergillosis. The Journal of Immunology, 165, 381-388. https://doi.org/10.4049/jimmunol.165.1.381
|
[23]
|
Lin, J.S. and Wu-Hsieh, B.A. (2004) Functional T Cells in Pri-mary Immune Response to Histoplasmosis. International Immunology, 16, 1663-1673. https://doi.org/10.1093/intimm/dxh168
|
[24]
|
Sparber, F. and Leibundgut-Landmann, S. (2019) Interleukin-17 in Antifungal Immunity. Pathogens, 8, 54.
https://doi.org/10.3390/pathogens8020054
|
[25]
|
Chai, L.Y., Van De Veerdonk, F., Marijnissen, R.J., et al. (2010) Anti-Aspergillus Human Host Defence Relies on Type 1 T Helper (Th1), Rather than Type 17 T Helper (Th17), Cellular Immunity. Immunology, 130, 46-54.
https://doi.org/10.1111/j.1365-2567.2009.03211.x
|
[26]
|
Curtis, M.M. and Way, S.S. (2009) Interleukin-17 in Host Defence against Bacterial, Mycobacterial and Fungal Pathogens. Immunology, 126, 177-185. https://doi.org/10.1111/j.1365-2567.2008.03017.x
|
[27]
|
De Beaucoudrey, L., Samarina, A., Bustamante, J., et al. (2010) Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients from 30 Countries. Medicine, 89, 381-402. https://doi.org/10.1097/MD.0b013e3181fdd832
|
[28]
|
Cypowyj, S., Picard, C., Maródi, L., et al. (2012) Immunity to Infection in IL-17-Deficient Mice and Humans. European Journal of Immunology, 42, 2246-2254. https://doi.org/10.1002/eji.201242605
|
[29]
|
Wiederhold, N.P. (2017) Antifungal Resistance: Current Trends and Future Strategies to Combat. Infection and Drug Resistance, 10, 249-259. https://doi.org/10.2147/IDR.S124918
|
[30]
|
Kumaresan, P.R., Da Silva, T.A. and Kontoyiannis, D.P. (2017) Meth-ods of Controlling Invasive Fungal Infections Using CD8+ T Cells. Frontiers in Immunology, 8, 1939. https://doi.org/10.3389/fimmu.2017.01939
|
[31]
|
Lauruschkat, C.D., Einsele, H. and Loeffler, J. (2018) Immuno-modulation as a Therapy for Aspergillus Infection: Current Status and Future Perspectives. Journal of Fungi (Basel), 4, 137. https://doi.org/10.3390/jof4040137
|
[32]
|
Jolink, H., De Boer, R., Hombrink, P., et al. (2017) Pulmonary Im-mune Responses against Aspergillus fumigatus Are Characterized by High Frequencies of IL-17 Producing T-Cells. Journal of Infection, 74, 81-88.
https://doi.org/10.1016/j.jinf.2016.10.010
|